Qin S, Chen Z, Fang W, Ren Z, et al. Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial. J Clin Oncol 2022 Dec 1:JCO2200620. doi: 10.1200/JCO.22.00620.
PMID: 36455168